Pagaya Reports Fourth Quarter and Full Year 2022 Results
Full Year 2022 Network Volume grew 49% year-over-year to
Fourth Quarter Network Volume grew 10% year-over-year to
Company provides 2023 financial outlook
“2022 was a record year for Pagaya,” said
Full Year and Fourth Quarter 2022 Financial Highlights
All comparisons are made versus the same period in 2021 unless otherwise stated
- Network Volume increased 49% to
$7.3 billion in FY22 and increased 10% to$1.8 billion in 4Q22, reflecting growth from existing partners and faster growth from newer products, including auto - Total revenue and other income increased 58% to
$748.9 million in FY22 and increased 25% to$192.9 million in 4Q22, mainly due to increased fee revenue from Network Volume growth - Net loss attributable to
Pagaya shareholders of$302.3 million in FY22 and$34.0 million in 4Q22, impacted by share-based compensation expense in both periods of$241.7 million and$18.7 million , respectively. Adjusted net loss of$32.7 million in FY22 and$3.7 million in 4Q22, which excludes share-based compensation expense, a change in fair value of warrant liability, other than temporary impairment loss on certain investments, impairment of goodwill and other intangible assets, and non-recurring expenses - Adjusted EBITDA of negative
$4.8 million in FY22 and negative$9.0 million in 4Q22, reflecting investment in newer products and partners and ongoing financial markets volatility
2022 Business Highlights
- Expanding the network: 6 partners joined the
Pagaya network in 2022, including a top 3 lender in auto andKlarna in the Company’s point-of-sale product. Pagaya’s solution is now connected to approximately 20,000 franchise and independent auto dealerships through its partners, with approximately$110 billion in auto application volume evaluated in 2022. The Company expanded its single-family rental (“SFR”) offering with the acquisition ofDarwin Homes , creating a technologically sophisticated, fully integrated property technology platform - Enabling better outcomes for partners & investors: Continued strong application flow from existing and new partners, with over 53 million applications evaluated in 2022, representing 98% growth compared to the prior year. At the same time, with the benefit of AI-driven insights, the Company proactively reduced its conversion ratio by nearly 50% year-over-year, optimizing for investor returns in this environment by shifting the portfolio to a more resilient borrower archetype
- Consistently raising capital: Raised over
$7 billion in funding into financing vehicles in FY22 - Improving operating efficiency: The Company remains focused on improving profitability and driving operating leverage with increasing scale and disciplined cost management. Its operating expense ratio, defined as operating expenses excluding stock-based compensation expense as a percentage of total revenue & other income, declined from 43% in the first half of 2022 to 39% in the second half of 2022
2023 Outlook
|
First Quarter of 2023 |
|
Network Volume |
Expected to range between |
|
Total Revenue |
Expected to range between |
|
Adjusted EBITDA |
Expected to range between negative |
|
Full Year 2023 |
|
Network Volume |
Expected to range between |
|
Total Revenue |
Expected to range between |
|
Adjusted EBITDA |
Expected to range between |
Webcast
The Company will hold a webcast and conference call today,
The conference call can also be accessed by dialing 1-877-407-9208 or 1-201-493-6784. The telephone replay can be accessed by dialing 1-844-512-2921 or 1-412-317-6671 and providing the conference ID# 13735076. The telephone replay will be available starting shortly after the call until
About
Cautionary Note About Forward-Looking Statements
This document contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that involve risks and uncertainties. These forward-looking statements generally are identified by the words “anticipate,” “believe,” “continue,” “can,” “could,” “estimate,” “expect,” “intend,” “may,” “opportunity,” “future,” “strategy,” “might,” “outlook,” “plan,” “possible,” “potential,” “predict,” “project,” “should,” “strive,” “will,” “would,” “will be,” “will continue,” “will likely result,” and similar expressions. All statements other than statements of historical fact are forward-looking statements, including statements regarding: the finalization of any adjustments identified by the Company’s auditors in the course of their review and audit, of the Company's financial statements for the fourth fiscal quarter and fiscal year ended
Financial Information; Non-GAAP Financial Measures
Some of the unaudited financial information and data contained in this press release and Form 6-K, such as Adjusted EBITDA, have not been prepared in accordance with
Non-GAAP financial measures include the following item:
Adjusted Net Income (Loss) is defined as net income (loss) attributable to Pagaya Technologies Ltd.’s shareholders excluding share-based compensation expense, change in fair value of warrant liability, and non-recurring expenses associated with the business combination with
Adjusted EBITDA is defined as net income (loss) attributable to Pagaya Technologies Ltd.’s shareholders excluding share-based compensation expense, change in fair value of warrant liability, non-recurring expenses associated with the Merger, interest expense, depreciation expense, and provision for income taxes.
These items are excluded from our Adjusted Net Income (Loss) and Adjusted EBITDA measures because they are noncash in nature, or because the amount and timing of these items is unpredictable, is not driven by core results of operations and renders comparisons with prior periods and competitors less meaningful.
We believe Adjusted Net Income (Loss) and Adjusted EBITDA provide useful information to investors and others in understanding and evaluating our results of operations, as well as providing a useful measure for period-to-period comparisons of our business performance. Moreover, we have included Adjusted Net Income (Loss) and Adjusted EBITDA because these are key measurements used by our management internally to make operating decisions, including those related to operating expenses, evaluate performance, and perform strategic planning and annual budgeting. However, this non-GAAP financial information is presented for supplemental informational purposes only, should not be considered a substitute for or superior to financial information presented in accordance with GAAP and may be different from similarly titled non-GAAP financial measures used by other companies. The tables below provide reconciliations of Adjusted EBITDA to Net Loss Attributable to
In addition, outlook for the fiscal year, where adjusted, is provided on a non-GAAP basis, which
|
|||||||||||||||
CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) |
|||||||||||||||
(In thousands, except share and per share data) |
|||||||||||||||
|
Three Months Ended |
|
Year Ended |
||||||||||||
|
2022 |
|
2021 |
|
2022 |
|
2021 |
||||||||
Revenue |
|
|
|
|
|
|
|
||||||||
Revenue from fees |
$ |
178,173 |
|
|
$ |
144,262 |
|
|
$ |
685,414 |
|
|
$ |
445,866 |
|
Other Income |
|
|
|
|
|
|
|
||||||||
Interest income |
|
14,631 |
|
|
|
10,621 |
|
|
|
57,758 |
|
|
|
28,877 |
|
Investment income (loss) |
|
86 |
|
|
|
(153 |
) |
|
|
5,756 |
|
|
|
(155 |
) |
Total Revenue and Other Income |
|
192,890 |
|
|
|
154,730 |
|
|
|
748,928 |
|
|
|
474,588 |
|
Costs and Operating Expenses |
|
|
|
|
|
|
|
||||||||
Production costs (1) |
|
124,709 |
|
|
|
78,450 |
|
|
|
451,084 |
|
|
|
232,324 |
|
Research and development (2) |
|
23,554 |
|
|
|
14,867 |
|
|
|
150,933 |
|
|
|
66,211 |
|
Sales and marketing (2) |
|
13,974 |
|
|
|
12,063 |
|
|
|
104,203 |
|
|
|
49,627 |
|
General and administrative (1)(2) |
|
57,350 |
|
|
|
51,536 |
|
|
|
294,213 |
|
|
|
132,235 |
|
Total Costs and Operating Expenses |
|
219,587 |
|
|
|
156,916 |
|
|
|
1,000,433 |
|
|
|
480,397 |
|
Operating Loss |
|
(26,697 |
) |
|
|
(2,186 |
) |
|
|
(251,505 |
) |
|
|
(5,809 |
) |
Other loss, net |
|
(34,715 |
) |
|
|
(4,300 |
) |
|
|
(24,869 |
) |
|
|
(55,839 |
) |
Loss Before Income Taxes |
|
(61,412 |
) |
|
|
(6,486 |
) |
|
|
(276,374 |
) |
|
|
(61,648 |
) |
Income tax expense (benefit) |
|
(9,204 |
) |
|
|
(3,542 |
) |
|
|
16,400 |
|
|
|
7,875 |
|
Loss Including Noncontrolling Interests |
|
(52,208 |
) |
|
|
(2,944 |
) |
|
|
(292,774 |
) |
|
|
(69,523 |
) |
Less: Net income (loss) attributable to noncontrolling interests |
|
(18,210 |
) |
|
|
7,512 |
|
|
|
9,547 |
|
|
|
21,628 |
|
Loss Attributable to |
$ |
(33,998 |
) |
|
$ |
(10,456 |
) |
|
$ |
(302,321 |
) |
|
$ |
(91,151 |
) |
Per share data: |
|
|
|
|
|
|
|
||||||||
Net loss attributable to |
$ |
(33,998 |
) |
|
$ |
(10,456 |
) |
|
$ |
(302,321 |
) |
|
$ |
(91,151 |
) |
Less: Undistributed earnings allocated to participated securities |
|
— |
|
|
|
(6,064 |
) |
|
|
(12,205 |
) |
|
|
(19,558 |
) |
Less: Deemed dividend distribution |
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(23,612 |
) |
Net loss attributed to |
$ |
(33,998 |
) |
|
$ |
(16,520 |
) |
|
$ |
(314,526 |
) |
|
$ |
(134,321 |
) |
Net loss per share attributable to |
|
|
|
|
|
|
|
||||||||
Basic and Diluted (3) |
$ |
(0.05 |
) |
|
$ |
(0.08 |
) |
|
$ |
(0.69 |
) |
|
$ |
(0.69 |
) |
Non-GAAP adjusted net income (loss) (4) |
$ |
(3,683 |
) |
|
$ |
380 |
|
|
$ |
(32,664 |
) |
|
$ |
37,259 |
|
Non-GAAP adjusted net income (loss) per share: |
|
|
|
|
|
|
|
||||||||
Basic (3) |
$ |
(0.01 |
) |
|
$ |
0.00 |
|
|
$ |
(0.07 |
) |
|
$ |
0.19 |
|
Diluted (3) |
$ |
(0.01 |
) |
|
$ |
0.00 |
|
|
$ |
(0.07 |
) |
|
$ |
0.14 |
|
Weighted average shares outstanding (Class A and Class B): |
|
|
|
|
|
|
|
||||||||
Basic (3) |
|
688,165,887 |
|
|
|
197,751,810 |
|
|
|
459,044,846 |
|
|
|
195,312,586 |
|
Diluted (3) |
|
697,441,165 |
|
|
|
448,116,776 |
|
|
|
699,631,838 |
|
|
|
262,995,525 |
|
(1) Certain amounts included for the three months ended
(2) The following table sets forth share-based compensation for the periods indicated below:
|
Three Months Ended |
|
Year Ended |
||||||||
|
2022 |
|
2021 |
|
2022 |
|
2021 |
||||
Research and development |
$ |
4,886 |
|
$ |
800 |
|
$ |
81,337 |
|
$ |
27,042 |
Selling and marketing |
|
3,843 |
|
|
1,048 |
|
|
58,377 |
|
|
18,458 |
General and administrative |
|
9,953 |
|
|
2,963 |
|
|
101,975 |
|
|
22,285 |
Total |
$ |
18,682 |
|
$ |
4,811 |
|
$ |
241,689 |
|
$ |
67,785 |
(3) Prior period amounts have been retroactively adjusted to reflect the 1:186.9 stock split effected on
(4) See “Reconciliation of Non-GAAP Financial Measures” for a reconciliation of this and adjusted EBITDA, another non-GAAP measure.
|
||||||||
CONSOLIDATED STATEMENTS OF FINANCIAL POSITION (UNAUDITED) |
||||||||
(In thousands) |
||||||||
|
|
|||||||
|
2022 |
|
2021 |
|||||
Assets |
|
|
|
|||||
Current assets: |
|
|
|
|||||
Cash and cash equivalents |
$ |
309,793 |
|
|
$ |
190,778 |
|
|
Restricted cash |
|
22,539 |
|
|
|
7,000 |
|
|
Short-term deposits |
|
— |
|
|
|
5,020 |
|
|
Fees receivable |
|
59,219 |
|
|
|
32,332 |
|
|
Investments in loans and securities |
|
1,007 |
|
|
|
5,142 |
|
|
Prepaid expenses and other current assets |
|
27,258 |
|
|
|
6,263 |
|
|
Total current assets |
|
419,816 |
|
|
|
246,535 |
|
|
Restricted cash |
|
4,744 |
|
|
|
6,797 |
|
|
Fees receivable |
|
38,774 |
|
|
|
19,208 |
|
|
Investments in loans and securities |
|
462,969 |
|
|
|
277,582 |
|
|
Equity method and other investments |
|
25,894 |
|
|
|
14,841 |
|
|
Right-of-use asset |
|
61,077 |
|
|
|
— |
|
|
Property and equipment, net |
|
31,663 |
|
|
|
7,648 |
|
|
Deferred tax assets, net |
|
— |
|
|
|
5,681 |
|
|
Deferred offering costs |
|
— |
|
|
|
11,966 |
|
|
Prepaid expenses and other assets |
|
142 |
|
|
|
— |
|
|
Total non-current assets |
|
625,263 |
|
|
|
343,723 |
|
|
Total Assets |
$ |
1,045,079 |
|
|
$ |
590,258 |
|
|
Liabilities, Redeemable convertible preferred shares, and Shareholders’ Equity |
|
|
|
|||||
Current liabilities: |
|
|
|
|||||
Accounts payable |
$ |
1,739 |
|
|
$ |
11,580 |
|
|
Accrued expenses and other liabilities |
|
49,496 |
|
|
|
17,093 |
|
|
Operating lease liability - current |
|
8,530 |
|
|
|
— |
|
|
Secured borrowing - current |
|
61,829 |
|
|
|
— |
|
|
Income taxes payable - current |
|
6,424 |
|
|
|
— |
|
|
Total current liabilities |
|
128,018 |
|
|
|
28,673 |
|
|
Non-current liabilities: |
|
|
|
|||||
Warrant liability |
|
1,400 |
|
|
|
27,469 |
|
|
Revolving credit facility |
|
15,000 |
|
|
|
— |
|
|
Secured borrowing - non-current |
|
77,802 |
|
|
|
37,905 |
|
|
Operating lease liability - non-current |
|
49,097 |
|
|
|
— |
|
|
Income taxes payable - non-current |
|
7,771 |
|
|
|
11,812 |
|
|
Deferred tax liabilities, net - non-current |
|
568 |
|
|
|
— |
|
|
Total non-current liabilities |
|
151,638 |
|
|
|
77,186 |
|
|
Total liabilities |
|
279,656 |
|
|
|
105,859 |
|
|
Redeemable convertible preferred shares |
|
— |
|
|
|
307,047 |
|
|
Shareholders’ equity (deficit): |
|
|
|
|||||
Additional paid-in capital |
|
968,432 |
|
|
|
113,170 |
|
|
Accumulated other comprehensive income loss |
|
(713 |
) |
|
|
— |
|
|
Accumulated deficit |
|
(414,199 |
) |
|
|
(111,878 |
) |
|
|
|
553,520 |
|
|
|
1,292 |
|
|
Noncontrolling interests |
|
211,903 |
|
|
|
176,060 |
|
|
Total shareholders’ equity |
|
765,423 |
|
|
|
177,352 |
|
|
Total Liabilities, Redeemable Convertible Preferred Shares and Shareholders’ Equity |
$ |
1,045,079 |
|
|
$ |
590,258 |
|
|
|||||||
CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) |
|||||||
(In thousands) |
|||||||
|
Year Ended |
||||||
|
2022 |
|
2021 |
||||
Cash flows from operating activities |
|
|
|
||||
Net loss including noncontrolling interests |
$ |
(292,774 |
) |
|
$ |
(69,523 |
) |
Adjustments to reconcile net income (loss) to net cash used in operating activities: |
|
|
|
||||
Equity method income (loss) |
|
(5,756 |
) |
|
|
155 |
|
Loss on sale of equity method investments |
|
— |
|
|
|
421 |
|
Depreciation and amortization |
|
6,294 |
|
|
|
815 |
|
Share-based compensation |
|
241,689 |
|
|
|
67,785 |
|
Fair value adjustment to warrant liability |
|
(11,088 |
) |
|
|
53,019 |
|
Issuance of ordinary shares related to commitment shares |
|
1,000 |
|
|
|
— |
|
Loss on investments in loans and securities |
|
15,007 |
|
|
|
— |
|
Loss on loans held-for-investment |
|
10,651 |
|
|
|
— |
|
Other than temporary impairment of investments in loans and securities |
|
33,704 |
|
|
|
— |
|
Impairment of goodwill and other intangible assets |
|
3,209 |
|
|
|
— |
|
Change in operating assets and liabilities: |
|
|
|
||||
Fees and other receivables |
|
(46,453 |
) |
|
|
(27,555 |
) |
Deferred tax assets, net |
|
5,681 |
|
|
|
(3,378 |
) |
Deferred tax liabilities, net |
|
568 |
|
|
|
— |
|
Prepaid expenses and other assets |
|
(23,227 |
) |
|
|
(4,738 |
) |
Right-of-use asset |
|
7,742 |
|
|
|
— |
|
Accounts payable |
|
(9,841 |
) |
|
|
10,999 |
|
Accrued expenses and other liabilities |
|
32,403 |
|
|
|
13,407 |
|
Operating lease liability |
|
(11,192 |
) |
|
|
— |
|
Income tax payable |
|
2,383 |
|
|
|
8,404 |
|
Net cash (used in) provided by operating activities |
|
(40,000 |
) |
|
|
49,811 |
|
Cash flows from investing activities |
|
|
|
||||
Proceeds from the sale/maturity/prepayment of: |
|
|
|
||||
Investments in loans and securities |
|
112,897 |
|
|
|
28,904 |
|
Short-term deposits |
|
5,020 |
|
|
|
53,412 |
|
Equity method and other investments |
|
453 |
|
|
|
8,925 |
|
Payments for the purchase of: |
|
|
|
||||
Investments in loans and securities |
|
(355,633 |
) |
|
|
(202,366 |
) |
Property and equipment |
|
(22,406 |
) |
|
|
(6,624 |
) |
Equity method and other investments |
|
(5,750 |
) |
|
|
(22,991 |
) |
Net cash used in investing activities |
|
(265,419 |
) |
|
|
(140,740 |
) |
Cash flows from financing activities |
|
|
|
||||
Proceeds from sale of ordinary shares in connection with the Business Combination and PIPE |
|
291,872 |
|
|
|
— |
|
Proceeds from issuance of redeemable convertible preferred shares, net |
|
— |
|
|
|
172,645 |
|
Proceeds from issuance of ordinary share warrants, net |
|
— |
|
|
|
20,807 |
|
Proceeds from secured borrowing |
|
139,413 |
|
|
|
37,905 |
|
Proceeds received from noncontrolling interests |
|
105,469 |
|
|
|
151,035 |
|
Proceeds from revolving credit facility |
|
42,100 |
|
|
|
— |
|
Proceeds from exercise of stock options |
|
1,617 |
|
|
|
346 |
|
Proceeds from exercise of redeemable convertible preferred shares warrants |
|
— |
|
|
|
400 |
|
Distribution made to noncontrolling interests |
|
(77,764 |
) |
|
|
(81,548 |
) |
Distribution made to revolving credit facility |
|
(27,100 |
) |
|
|
— |
|
Distribution made to secured borrowing |
|
(37,687 |
) |
|
|
— |
|
Payment for deferred offering costs |
|
— |
|
|
|
(11,966 |
) |
Net cash provided by financing activities |
|
437,920 |
|
|
|
289,624 |
|
Net increase in cash, cash equivalents and restricted cash |
|
132,501 |
|
|
|
198,695 |
|
Cash, cash equivalents and restricted cash, beginning of period |
|
204,575 |
|
|
|
5,880 |
|
Cash, cash equivalents and restricted cash, end of period |
$ |
337,076 |
|
|
$ |
204,575 |
|
|
|||||||||||||||
RECONCILIATION OF NON-GAAP FINANCIAL MEASURES (UNAUDITED) |
|||||||||||||||
(In thousands) |
|||||||||||||||
|
Three Months Ended |
|
Year Ended |
||||||||||||
|
2022 |
|
2021 |
|
2022 |
|
2021 |
||||||||
Net Loss Attributable to |
$ |
(33,998 |
) |
|
$ |
(10,456 |
) |
|
$ |
(302,321 |
) |
|
$ |
(91,151 |
) |
Adjusted to exclude the following: |
|
|
|
|
|
|
|
||||||||
Share-based compensation |
|
18,682 |
|
|
|
4,811 |
|
|
|
241,689 |
|
|
|
67,785 |
|
Fair value adjustment to warrant liability |
|
(1,680 |
) |
|
|
1,542 |
|
|
|
(11,088 |
) |
|
|
53,019 |
|
Other than temporary impairment loss on certain investments |
|
8,836 |
|
|
|
— |
|
|
|
8,836 |
|
|
|
— |
|
Impairment of goodwill and other intangible assets |
|
3,209 |
|
|
|
— |
|
|
|
3,209 |
|
|
|
— |
|
Non-recurring expenses |
|
1,268 |
|
|
|
4,483 |
|
|
|
27,011 |
|
|
|
7,606 |
|
Adjusted Net Income (Loss) |
|
(3,683 |
) |
|
|
380 |
|
|
|
(32,664 |
) |
|
|
37,259 |
|
Adjusted to exclude the following: |
|
|
|
|
|
|
|
||||||||
Interest expenses |
|
1,716 |
|
|
|
— |
|
|
|
5,136 |
|
|
|
— |
|
Provision for income tax |
|
(9,204 |
) |
|
|
(3,542 |
) |
|
|
16,400 |
|
|
|
7,875 |
|
Depreciation and amortization |
|
2,217 |
|
|
|
326 |
|
|
|
6,294 |
|
|
|
815 |
|
Adjusted EBITDA |
$ |
(8,954 |
) |
|
$ |
(2,836 |
) |
|
$ |
(4,834 |
) |
|
$ |
45,949 |
|
1 The results reported herein and attached financial statements are unaudited.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230215005370/en/
Investors & Analysts
Head of Investor Relations
IR@pagaya.com
Media & Press
Head of
Press@pagaya.com
Source: